☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Dulaglutide
Eli Lilly's Trulicity (dulaglutide) Receives the US FDA's Approval for Additional Doses to Treat Type 2 Diabetes
September 4, 2020
Eli Lilly's Trulicity (dulaglutide) Receives CHMP Recommendation for Label Update to Include Results from REWIND Study
September 20, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.